Steven Cohen Foghorn Therapeutics Inc. Transaction History

Point72 Asset Management, L.P.

$39.3 Billion
Q1 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 437,369 shares of FHTX stock, worth $2.13 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

437,369

Previous 540,000 19.01%

Holding current value

$2.13 Million

Previous $3.48 Million 15.76%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$2.82 - $7.94 $289,419 - $814,890	-102,631 Reduced 19.01%	437,369 $2.93 Million
Q4 2023 Feb 14, 2024	BUY	$2.94 - $6.76 $750,126 - $1.72 Million	255,145 Added 89.57%	540,000 $3.48 Million
Q3 2023 Nov 14, 2023	BUY	$5.0 - $9.87 $28,500 - $56,258	5,700 Added 2.04%	284,855 $1.42 Million
Q2 2023 Aug 14, 2023	BUY	$5.37 - $8.84 $1.5 Million - $2.47 Million	279,155 New	279,155 $1.97 Million
Q1 2023 May 15, 2023	SELL	$4.66 - $8.99 $153,780 - $296,670	-33,000 Closed	0 $0

Q4 2022 Feb 14, 2023	SELL	$5.44 - $9.46 $1.93 Million - $3.36 Million	-355,600 Reduced 91.51%	33,000 $210,000
Q3 2022 Nov 14, 2022	BUY	$7.52 - $18.01 $94,752 - $226,926	12,600 Added 3.35%	388,600 $3.33 Million
Q2 2022 Aug 15, 2022	BUY	$8.48 - $16.84 $3.14 Million - $6.24 Million	370,800 Added 7130.77%	376,000 $5.11 Million
Q1 2022 May 16, 2022	SELL	$8.87 - $22.1 $3.36 Million - $8.36 Million	-378,272 Reduced 98.64%	5,200 $79,000
Q4 2021 Feb 14, 2022	BUY	$10.79 - $22.87 $4.14 Million - $8.77 Million	383,472 New	383,472 $8.77 Million
Q2 2021 Aug 16, 2021	SELL	$9.32 - $13.26 $1.02 Million - $1.45 Million	-109,200 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$11.8 - $23.11 $1.29 Million - $2.52 Million	109,200 New	109,200 $1.44 Million

Others Institutions Holding FHTX

# of Institutions

Shares Held

23.6M

Call Options Held

7.7K

Put Options Held

1.4K

View Full List

About Foghorn Therapeutics Inc.

Ticker FHTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,637,400
Market Cap $203M
Description
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...

More about FHTX

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account